Research
OCRA invests more funds into ovarian cancer research than any other public charity.
Mission & Impact
OCRA is dedicated to improving treatments by advancing innovative research, supporting with expertise and empathy those affected by gynecologic cancers to ensure the best possible care and outcomes, raising awareness, and advocating for legislation that tangibly improves patients’ lives. Alongside these efforts, we continue to press forward in our search for a desperately needed cure.
Results and Milestones
Numbers tell the story of our impact
- Research and Education Funding
- OCRA’s advocacy efforts have helped secure $3.8 billion in federal research and education funding
- $3.8B
- Invested in Science Innovation
- $122M raised and invested in scientific breakthroughs
- $122M
- Individuals Helped Each Year
- Our programs support tens of thousands of individuals annually
- 95K
For each dollar we spend, 81 cents goes to funding critical research and innovative programs
Advancing Research and Fueling Hope
OCRA has both a laser focus and a panoramic view when it comes to the fight against gynecologic cancers.
Advocacy
OCRA has built a team of passionate, dedicated advocates.
Patient Support
In times of adversity, support becomes a beacon of hope.
OCRA's History of Impact and Innovation
Ovarian Cancer Research Alliance (OCRA) is the oldest and largest ovarian and gynecologic cancer charity in the world. Since its founding in 1994, OCRA has grown into the leading non-government funder of ovarian and related gynecologic cancer research, investing over $122 million in groundbreaking studies. Through innovative education and advocacy efforts, compassionate support programs, and cross-industry collaboration, OCRA is driving progress and pushing the boundaries of what’s possible to improve outcomes for patients and advance research in its quest for a cure.
Related Topics
OCRA’s Ovarian Cycle Tampa Fundraiser Recognized by ABC Action News Tampa
OCRA’s Ovarian Cycle Tampa marked its 12th year of raising funds and awareness for ovarian cancer research this past weekend, as reported by WFTS-TV ABC Action News Tampa Bay’s Robert … Continued
Harper’s Bazaar Honors the Legacy of Liz Tilberis, Our Organization’s First President
Harper’s Bazaar has published a powerful new piece by Chris Tilberis, who serves on OCRA’s Board of Directors, reflecting on his mother Liz Tilberis’ remarkable career as the former editor-in-chief … Continued
OCRA Champions Access and Equity in Ovarian Cancer and Gynecologic Cancer Awareness Month
As Ovarian and Gynecologic Cancer Awareness Month begins, Ovarian Cancer Research Alliance (OCRA) is proud to highlight a series of initiatives aimed at expanding access and promoting equity in ovarian and … Continued